Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
{{output}}
Background: Levodopa-entacapone-carbidopa intestinal gel (LECIG) was introduced on the Swedish market in 2019. The therapy is aimed at patients with Parkinson's disease (PD) with fluctuations and dyskinesias. Long-term efficacy a... ...
